James A. Mansi, PhD

Head, Center for Outcomes Research & Evaluation
Seqirus

Disclosure: Seqirus (Employee)

Presentation(s):

• LB-2 - Relative Effectiveness of aIIV3 versus IIV4 and HD-IIV3 In Preventing Influenza-Related Medical Encounters in Adults ≥65 Years of Age at High Risk for Influenza Complications During the U.S. 2017-2018 and 2018-2019 Influenza Seasons

  Saturday, October 24, 2020
  10:00am – 10:10am EDT